Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Joel Marrs to Humans

This is a "connection" page, showing publications Joel Marrs has written about Humans.

 
Connection Strength
 
 
 
0.401
 
  1. White BM, Anderson SL, Marrs JC. Antihypertensive prescribing patterns and hypertension control in females of childbearing age. Am J Health Syst Pharm. 2021 07 09; 78(14):1317-1322.
    View in: PubMed
    Score: 0.026
  2. Anderson SL, Marrs JC. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation? Curr Cardiol Rep. 2019 08 31; 21(10):118.
    View in: PubMed
    Score: 0.023
  3. Anderson SL, Marrs JC. A Review of the Role of the Pharmacist in Heart Failure Transition of Care. Adv Ther. 2018 03; 35(3):311-323.
    View in: PubMed
    Score: 0.021
  4. Kelly MS, Saseen JJ, Marrs JC. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations. Ther Adv Cardiovasc Dis. 2017 Feb; 11(2):63-71.
    View in: PubMed
    Score: 0.019
  5. Marrs JC, Kostoff MD. Discontinuation of Statins: What Are the Risks? Curr Atheroscler Rep. 2016 Jul; 18(7):41.
    View in: PubMed
    Score: 0.018
  6. Marrs JC, Thompson AM. Antihypertensive Therapy in Females: A Clinical Review Across the Lifespan. Pharmacotherapy. 2016 06; 36(6):638-51.
    View in: PubMed
    Score: 0.018
  7. Amin A, Marrs JC. Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes. Clin Appl Thromb Hemost. 2016 Oct; 22(7):605-16.
    View in: PubMed
    Score: 0.017
  8. Marrs JC. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2015 04 02; 372(14):1372.
    View in: PubMed
    Score: 0.017
  9. Wobeter BR, Anderson SL, Marrs JC. Characterization of diastolic dysfunction heart failure following an acute hospitalization for heart failure in an urban, underserved population. Ther Adv Cardiovasc Dis. 2015 Oct; 9(5):267-74.
    View in: PubMed
    Score: 0.017
  10. Fosmire Rundgren EW, Anderson SL, Marrs JC. Response to comment "Evaluation of aspirin use for primary prevention in diabetic patients". Ann Pharmacother. 2015 Feb; 49(2):262-3.
    View in: PubMed
    Score: 0.017
  11. Fosmire Rundgren EW, Anderson SL, Marrs JC. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015 Feb; 49(2):170-7.
    View in: PubMed
    Score: 0.016
  12. Marrs JC. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl. Drugs Aging. 2012 May 01; 29(5):e1-e12.
    View in: PubMed
    Score: 0.014
  13. Anderson SL, Marrs JC. Dapagliflozin for the treatment of type 2 diabetes. Ann Pharmacother. 2012 Apr; 46(4):590-8.
    View in: PubMed
    Score: 0.014
  14. Marrs JC. Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease. Am J Manag Care. 2011 Dec; 17 Suppl 15:S403-11.
    View in: PubMed
    Score: 0.013
  15. Marrs JC. Spironolactone management of resistant hypertension. Ann Pharmacother. 2010 Nov; 44(11):1762-9.
    View in: PubMed
    Score: 0.012
  16. Marrs JC, Saseen JJ. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy. 2010 Aug; 30(8):823-9.
    View in: PubMed
    Score: 0.012
  17. Marrs JC, Rackham DM. Residents' challenging role: Preceptee, preceptor, or both? Am J Health Syst Pharm. 2010 Feb 01; 67(3):239-43.
    View in: PubMed
    Score: 0.012
  18. Marrs JC. Colesevelam for the management of type 2 diabetes. Expert Opin Drug Metab Toxicol. 2009 Feb; 5(2):187-94.
    View in: PubMed
    Score: 0.011
  19. Marrs JC. Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia. Ann Pharmacother. 2008 Jul; 42(7):1070-9.
    View in: PubMed
    Score: 0.011
  20. Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9.
    View in: PubMed
    Score: 0.010
  21. Marrs JC, Saseen JJ. Which patients are candidates for dipeptidyl peptidase IV inhibitors? Am J Health Syst Pharm. 2007 Jun; 64(12):1261.
    View in: PubMed
    Score: 0.010
  22. Marrs JC. Family medicine pharmacy residency programs. Am J Health Syst Pharm. 2006 Oct 01; 63(19):1803-5.
    View in: PubMed
    Score: 0.009
  23. Glasgow RE, Knoepke CE, Magid D, Grunwald GK, Glorioso TJ, Waughtal J, Marrs JC, Bull S, Ho PM. The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: study protocol for a randomized controlled trial. Trials. 2021 Aug 11; 22(1):528.
    View in: PubMed
    Score: 0.007
  24. Anderson SL, Marrs JC, Chachas CR, Cichon BS, Cizmic AD, Calderon BB, Vlasimsky TB. Evaluation of a Pharmacist-Led Intervention to Improve Statin Use in Persons with Diabetes. J Manag Care Spec Pharm. 2020 Jul; 26(7):910-917.
    View in: PubMed
    Score: 0.006
  25. Wiggins BS, Dixon D, Bellone J, Gasbarro N, Marrs JC, Tran R. Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894.
    View in: PubMed
    Score: 0.006
  26. Luoma KA, Leavitt IM, Marrs JC, Nederveld AL, Regensteiner JG, Dunn AL, Glasgow RE, Huebschmann AG. How can clinical practices pragmatically increase physical activity for patients with type 2 diabetes? A systematic review. Transl Behav Med. 2017 12; 7(4):751-772.
    View in: PubMed
    Score: 0.005
  27. Jordan RP, Bratberg J, Congdon HB, Cross LB, Hill LG, Marrs JC, McBane S, Lang WG, Ekoma JO. The Report of the 2016-2017 Advocacy Standing Committee. Am J Pharm Educ. 2017 Oct; 81(8):S10.
    View in: PubMed
    Score: 0.005
  28. Anderson SL, Kattappuram RS, Marrs JC, Joseph NM. Intentional Brodifacoum Ingestion. Am J Med. 2017 Jan; 130(1):e27-e28.
    View in: PubMed
    Score: 0.005
  29. Zupec JF, Marrs JC, Saseen JJ. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Ann Pharmacother. 2016 Jan; 50(1):17-21.
    View in: PubMed
    Score: 0.004
  30. Anderson SL, Marrs JC, Vande Griend JP, Hanratty R. Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home. Popul Health Manag. 2013 Aug; 16(4):235-41.
    View in: PubMed
    Score: 0.004
  31. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the acute management and secondary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e115-42.
    View in: PubMed
    Score: 0.004
  32. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e101-14.
    View in: PubMed
    Score: 0.004
  33. Toussaint KA, Watson K, Marrs JC, Sturpe DA, Anderson SL, Haines ST. Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy. 2013 Jan; 33(1):105-11.
    View in: PubMed
    Score: 0.004
  34. Haines ST, Andrus MR, Badowski M, Bradbury MM, Canales AE, Cavanaugh JM, Koval PG, Lee MW, Marrs JC, Michael Nash J, Ott CA, Robbins Williams A, Wham DL. Board Certification of Pharmacist Specialists. Pharmacotherapy. 2011 Nov; 31(11):1146-9.
    View in: PubMed
    Score: 0.003
  35. Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011 Dec; 58(6):1008-13.
    View in: PubMed
    Score: 0.003
  36. Blair MM, Freitag RT, Keller DL, Kiser TH, Marrs JC, McGivney MS, Mohammad RA, Twedt EL. Proposed revision to the existing specialty and specialist certification framework for pharmacy practitioners. Pharmacotherapy. 2009 Apr; 29(4):3e-13e.
    View in: PubMed
    Score: 0.003
  37. Ito MK, Marrs J, Williams C. Omacor effects on serum lipids and clinical outcome. Am J Cardiol. 2007 Jan 01; 99(1):145.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)